Memphasys Ltd (AU:MEM) has released an update.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Memphasys Ltd has extended its Share Purchase Plan closing date to October 31, 2024, following shareholder feedback requesting more time to consider the offer. The initiative aims to raise up to $3 million, funding projects like the Felix clinical trial and equine fertility study. This extension provides investors additional opportunities to engage with Memphasys’ promising biotechnology advancements.
For further insights into AU:MEM stock, check out TipRanks’ Stock Analysis page.
